Search company, investor...
Evidation company logo


Founded Year



Series E | Alive

Total Raised




Last Raised

$153M | 2 yrs ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+30 points in the past 30 days

About Evidation

Evidation operates as a multichannel health tracking platform. It enables users to connect with multiple appications to track everyday activity and earn rewards for steps, sleep, surveys, and more. The company was founded in 2012 and is based in San Mateo, California.

Headquarters Location

63 Bovet Road Suite 146

San Mateo, California, 94402,

United States


ESPs containing Evidation

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Healthcare & Life Sciences / Health Data & Analytics

The patient-reported outcomes market provides software solutions to collect and analyze data directly from patients about their health status, symptoms, and quality of life. These platforms allow patients to report their own outcomes and experiences, which can be used by healthcare providers and researchers to evaluate treatment effectiveness, quality of care, and patient satisfaction. The market …

Evidation named as Leader among 8 other companies, including OutcomeMD, Protera Health, and PatientIQ.

Compete with Evidation?

Ensure that your company and products are accurately represented on our platform.

Evidation's Products & Differentiators


    Evidation runs programs for enterprises to get actionable evidence in three areas: disease burden and patient impact, patient segmentation and identification, disease event and progression modelling. We deploy a proven approach, incorporating our experience with over 200 research programs, to reliably delivers results. Given our connectivity with highly engaged individuals, we deliver faster and more cost-effectively.

Expert Collections containing Evidation

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Evidation is included in 11 Expert Collections, including Unicorns- Billion Dollar Startups.


Unicorns- Billion Dollar Startups

1,215 items


Clinical Trials Tech

341 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.


Digital Health 150

300 items

2019's cohort of the most promising digital health startups transforming the healthcare industry


Value-Based Care & Population Health

1,259 items

The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.


Biopharma Tech

16,121 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Digital Health

10,347 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Evidation Patents

Evidation has filed 5 patents.

The 3 most popular patent topics include:

  • Smartwatches
  • Wearable computers
  • Wearable devices
patents chart

Application Date

Grant Date


Related Topics



Free instant messaging clients, Windows instant messaging clients, Instant messaging clients, Videotelephony, Cigarette brands


Application Date


Grant Date


Related Topics

Free instant messaging clients, Windows instant messaging clients, Instant messaging clients, Videotelephony, Cigarette brands



Latest Evidation News

Myovant Sciences and Evidation Announce Survey Results of Unseen Burdens at Work and School of Individuals with Endometriosis and/or Uterine Fibroids

May 17, 2023

SAN MATEO, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Today, as part of National Women’s Health Week, Evidation and Myovant Sciences Ltd. (“Myovant”), a wholly owned subsidiary of Sumitovant Biopharma Ltd. (“Sumitovant”) announced results from a survey exploring the lived experiences of individuals with endometriosis and/or uterine fibroids. The survey results highlight the negative impacts of these conditions on employee and student experiences and quality-of-life, underscoring the need for

Evidation Frequently Asked Questions (FAQ)

  • When was Evidation founded?

    Evidation was founded in 2012.

  • Where is Evidation's headquarters?

    Evidation's headquarters is located at 63 Bovet Road, San Mateo.

  • What is Evidation's latest funding round?

    Evidation's latest funding round is Series E.

  • How much did Evidation raise?

    Evidation raised a total of $259.18M.

  • Who are the investors of Evidation?

    Investors of Evidation include B Capital Group, McKesson Ventures, OMERS Private Equity, Kaiser Permanente Ventures, SV Health Investors and 12 more.

  • Who are Evidation's competitors?

    Competitors of Evidation include Clinerion, Medbanks Network Technology, nference, Komodo Health, Tempus, Neurocast, Curebase, Reify Health, ConcertAI, AllStripes and 16 more.

  • What products does Evidation offer?

    Evidation's products include Research.

Compare Evidation to Competitors

Aetion Logo

Aetion is a healthcare analytics company. It provides decision-grade real-world evidence solutions to biopharma companies, payers, and regulatory agencies. It offers a platform that analyzes data from the real world to produce scientifically validated answers on treatments, effectiveness, and value. The company was founded in 2012 and is based in New York, New York.


ObvioHealth develops ClaimIt, a proprietary digital platform that utilizes a 100% online and mobile app interface to execute clinical trials. ClaimIt removes the costly overhead of physical site visits and brings the trial directly to the mobile device of each subject.

Holmusk Logo

Holmusk builds an evidence platform with behavioral health combining behavioral health databases with artificial intelligence (AI) powered analytics and digital solutions. Its technology powers data-driven medicine that uses analytic and digital tools to address the need in healthcare and pharma-life science. The company was founded in 2015 and is based in Singapore, Singapore.

Medable Logo

Medable operates as a global platform for decentralized clinical trials. It solves the systemic challenges inherent in modern clinical trials including access, interoperability between systems, and inefficient technology experiences. It was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.

Syapse Logo

Syapse develops software for aggregating and structuring biomedical data. It combines data intelligence, insight analytics and applied experience through healthcare organizations looking to transform patients’ lives using real-world evidence. The company was founded in 2008 and is based in San Francisco, California.

Owkin Logo

Owkin specializes in artificial intelligence technologies applied to clinical research and developing drugs and treatments for patients. It empowers researchers in hospitals, universities, and the biopharma industry to understand drug efficacy varies, improves the drug development process, and help identify key drugs and treatments for individual patients to improve patient outcomes. The company was founded in 2016 and is based in New York, New York.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.